Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DNA study sheds light on myxoma resistance
Australia released myxomatosis in 1950 to tackle the burgeoning rabbit population.
Modern rabbits compared with specimens from before 1950s outbreak

An unprecedented rabbit DNA study has shed light on how rabbits have acquired resistance to myxomatosis.

Research led by the University of Cambridge and the CIBIO Institute in Porto looked at DNA from nearly 200 rabbits spanning 150 years and thousands of miles.

The team sequenced nearly 20,000 genes to pinpoint mutations since the myxomatosis pandemic in the 1950s.

According to findings published in the journal Science, modern rabbits in the UK, France and Australia, have acquired resistance to the myxoma virus through the same genetic changes. They also discovered that this process relied on lots of small mutations in different genes, rather than big changes in single genes.

Findings also suggest the protein that helps rabbits fight myxoma, also has an antiviral effect on an unrelated virus, vesicular stomatitis.

Miguel Carneiro, from CIBIO said: “While battling myxoma, rabbits may have increased their resistance to other viruses including, perhaps, rabbit haemorrhagic disease which is killing so many animals right now.”

Australia released myxomatosis in 1950 to tackle the burgeoning rabbit population, which was impacting the country’s native plants and animals. It is thought that the European rabbit was introduced to the country in the 1850s and within a century the population grew to hundreds of millions.

Within three months of releasing myxomatosis, it had spread 2,000km and killed 99 per cent of infected animals. It was illegally introduced to France in 1952 and spread to the UK in 1953, with similarly devastating consequences in all three countries.

Myxoma continues to present a serious threat to rabbits. Lead author Dr Joel Alves said: “Viral evolution appears to be finding ways to counter the genetic adaptations which we’ve observed. Recent, more virulent recent strains of myxoma virus, have been found to be extremely immunosuppressive. So the arms race goes on.”

As rabbit populations collapse across the UK and mainland Europe, researchers said the findings could provide clues to the future of the species.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.